Intermittent preventive antimalarial treatment in infancy

Intermittent preventive antimalarial treatment in infancy

Your July 26 Editorial1 endorses the findings of a report fromthe US Institute of Medicine (IOM)' on intermittent preventive treatment with sulfadoxinepyrimethamine in infancy (IPTi-SP).The IOM committee supported scaling up of IPTi-SP implementation in structured programmes.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2008-10, Vol.372 (9647), p.1383-1384
1. Verfasser: Anon
Format: Artikel
Sprache:eng
Schlagworte:
Antimalarials - administration & dosage
Antimalarials - adverse effects
Drug Administration Schedule
Drug Combinations
Humans
Infant
Internal Medicine
Malaria
Malaria - mortality
Malaria - prevention & control
Medical research
Pyrimethamine - administration & dosage
Pyrimethamine - adverse effects
Studies
Sulfadoxine - administration & dosage
Sulfadoxine - adverse effects
Treatment Failure
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Your July 26 Editorial1 endorses the findings of a report fromthe US Institute of Medicine (IOM)' on intermittent preventive treatment with sulfadoxinepyrimethamine in infancy (IPTi-SP).The IOM committee supported scaling up of IPTi-SP implementation in structured programmes.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(08)61583-4